Is ACIXF or MRK a better dividend investment in 2026?

ACIXF currently yields 6896.55% with a 5% 5-year dividend growth rate. MRK yields 3.25% with 8.2% growth. The better choice depends on your goal: ACIXF offers higher current income.

What is the dividend yield difference between ACIXF and MRK?

ACIXF has a forward dividend yield of 6896.55% ($2.00/share annually). MRK yields 3.25% ($3.08/share annually). The yield gap is 6893.30 percentage points.

Home › Compare › ACIXF vs MRK

ACIXF vs MRK: Dividend Comparison 2026

ACIXF yields 6896.55% · MRK yields 3.25%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 ACIXF wins by $1432605808592863.25M in total portfolio value

INVESTMENT

TIME HORIZON10 years

ACIXF

● Live price

6896.55%

Share price

$0.03

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$1432605808592863.25M

Annual income

$1,392,875,843,310,163,600,000.00

Full ACIXF calculator →

MRK

Merck & Co. Inc.

● Live price

3.25%

Share price

$94.80

Annual div

$3.08

5Y div CAGR

8.2%

Payout ratio

42%

After 10 yrs · $10,000 · DRIP

Portfolio value

$30.7K

Annual income

$950.29

Full MRK calculator →

Portfolio growth — ACIXF vs MRK

📍 ACIXF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	ACIXF	MRK
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, ACIXF + MRK cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

ACIXF pays

MRK pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ACIXF

Annual income on $10K today (after 15% tax)

$586,206.90/yr

After 10yr DRIP, annual income (after tax)

$1,183,944,466,813,639,000,000.00/yr

MRK

Annual income on $10K today (after 15% tax)

$276.16/yr

After 10yr DRIP, annual income (after tax)

$807.75/yr

At 15% tax rate, ACIXF beats the other by $1,183,944,466,813,639,000,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ACIXF + MRK for your $10,000?

ACIXF: 50%MRK: 50%

100% MRK50/50100% ACIXF

Portfolio after 10yr

$716302904296431.63M

Annual income

$696,437,921,655,081,800,000.00/yr

Blended yield

97.23%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

ACIXF

No analyst data

Altman Z

-3.2

Piotroski

1/9

MRK

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$128.54

+35.6% upside vs current

Range: $100.00 — $150.00

Altman Z

4.0

Piotroski

6/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ACIXF buys

MRK buys

No recent congressional trades found for ACIXF or MRK in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricACIXFMRK

Forward yield	6896.55% ✓	3.25%
Annual dividend / share	$2.00	$3.08 ✓
Payout ratio	50%	42% ✓
1-year div growth	0%	5.5% ✓
5-year div CAGR	0%	8.2% ✓
Portfolio after 10y	$1432605808592863.25M ✓	$30.7K
Annual income after 10y	$1,392,875,843,310,163,600,000.00 ✓	$950.29
Total dividends collected	$1429942114786334.00M ✓	$6.1K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: ACIXF vs MRK ($10,000, DRIP)

Year	ACIXF Portfolio	ACIXF Income/yr	MRK Portfolio	MRK Income/yr	Gap
1← crossover	$700,355	$689,655.17	$11,192	$351.54	+$689.2K → ACIXF
2	$45,889,900	$45,140,520.30	$12,524	$392.70	+$45.88M → ACIXF
3	$2,813,379,172	$2,764,276,978.38	$14,015	$438.65	+$2813.37M → ACIXF
4	$161,393,449,836	$158,383,134,122.24	$15,682	$489.96	+$161393.43M → ACIXF
5	$8,664,159,276,546	$8,491,468,285,221.65	$17,547	$547.23	+$8664159.26M → ACIXF
6	$435,300,017,392,982	$426,029,366,967,078.00	$19,632	$611.16	+$435300017.37M → ACIXF
7	$20,469,824,923,231,620	$20,004,053,904,621,130.00	$21,963	$682.53	+$20469824923.21M → ACIXF
8	$901,046,035,934,427,400	$879,143,323,266,569,700.00	$24,571	$762.18	+$901046035934.40M → ACIXF
9	$37,130,808,675,420,410,000	$36,166,689,416,970,576,000.00	$27,486	$851.08	+$37130808675420.39M → ACIXF
10	$1,432,605,808,592,863,400,000	$1,392,875,843,310,163,600,000.00	$30,745	$950.29	+$1432605808592863.25M → ACIXF

ACIXF vs MRK: Complete Analysis 2026

ACIXF — Stock

Acarix AB (publ), a medical device company, develops solutions for rapid AI-based coronary artery disease (CAD) rule-out in Sweden and internationally. It offers CADScor System, a point-of-care diagnostic aid that uses sensitive acoustics and advanced AI to analyse the patient's coronary blood flow. The company was founded in 2009 and is headquartered in Malmö, Sweden.

Full ACIXF Calculator →

MRK — Healthcare

Merck is a Dividend Aristocrat with 14+ consecutive years of increases. Keytruda (pembrolizumab) is the world's best-selling cancer drug and drives exceptional cash generation. The company's oncology and vaccines pipeline provides long-term growth visibility beyond the Keytruda patent cliff in the 2030s.

Full MRK Calculator →

📬

Get this ACIXF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ACIXF vs SCHD ACIXF vs JEPI ACIXF vs O ACIXF vs KO ACIXF vs MAIN ACIXF vs JNJ ACIXF vs ABBV ACIXF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.